Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial

Title
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial
Authors
Keywords
Pertussis vaccine, Epicutaneous vaccination, Needleless vaccine, Recombined pertussis toxin, Immune response, Randomized trial
Journal
CLINICAL MICROBIOLOGY AND INFECTION
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-09-06
DOI
10.1016/j.cmi.2020.08.033

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started